+27.9%
VTV vs GSK
+14.9%
+13.0%
-6.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | +5.0% | -3.5% | +0.7% |
| 7D | +1.8% | +4.9% | -3.2% | +1.0% |
| 30D | +6.0% | +9.9% | -3.9% | +4.3% |
| 3M | +3.7% | +0.2% | +3.5% | +3.6% |
| 6M | +13.9% | +2.3% | +11.6% | +13.3% |
| YTD | +22.8% | +7.1% | +15.7% | +20.3% |
| 1Y | +27.9% | +13.1% | +14.8% | +23.5% |
| All | +27.9% | +14.9% | +13.0% | +23.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling